Last 12 months
Inside the activity.
6 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 6 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 26, 2018 Filed Jun 28, 2018 21:59 UTC |
FOLLIARD THOMAS JDirector
|
SaleCommon Stock | 195,600 | $75.49 | $14,765,844.00 |
DisclosureSEC source: 0001170010-18-000115 · wf-form4_153022316259007.xml · nonDerivative · entry 5 FOLLIARD THOMAS J · CIK 0001223841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,062 F3 · price: The shares with respect to this transaction were sold at prices ranging from $75.30 to $75.80. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:59 UTC |
FOLLIARD THOMAS JDirector
|
SaleCommon Stock | 7,652 | $76.17 | $582,852.84 |
DisclosureSEC source: 0001170010-18-000115 · wf-form4_153022316259007.xml · nonDerivative · entry 4 FOLLIARD THOMAS J · CIK 0001223841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,662 F2 · price: The shares with respect to this transaction were sold at prices ranging from $76.00 to $76.39. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:59 UTC |
FOLLIARD THOMAS JDirector
|
SaleCommon Stock | 100,000 | $75.46 | $7,546,000.00 |
DisclosureSEC source: 0001170010-18-000115 · wf-form4_153022316259007.xml · nonDerivative · entry 3 FOLLIARD THOMAS J · CIK 0001223841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 462,314 F1 · price: The shares with respect to this transaction were sold at prices ranging from $75.18 to $75.90. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:59 UTC |
FOLLIARD THOMAS JDirector
|
Exercise / conversionCommon Stock | 207,673 | $42.68 | $8,863,483.64 |
DisclosureSEC source: 0001170010-18-000115 · wf-form4_153022316259007.xml · nonDerivative · entry 2 FOLLIARD THOMAS J · CIK 0001223841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:59 UTC |
FOLLIARD THOMAS JDirector
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000115 · wf-form4_153022316259007.xml · nonDerivative · entry 1 FOLLIARD THOMAS J · CIK 0001223841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,641 Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:59 UTC |
Daniels Jon GSVP, CAF
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $42.68 | $0.00 |
DisclosureSEC source: 0001170010-18-000114 · wf-form4_153022313567154.xml · derivative · entry 6 Daniels Jon G · CIK 0001628337 · SVP, CAF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-04-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options became exercisable with respect to one-fourth of the underlying shares of Common Stock on each of April 15, 2014, April 15, 2015, April 15, 2016 and April 15, 2017 and are now fully exercisable. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:59 UTC |
Daniels Jon GSVP, CAF
|
SaleCommon Stock | 8,484 | $76.01 | $644,868.84 |
DisclosureSEC source: 0001170010-18-000114 · wf-form4_153022313567154.xml · nonDerivative · entry 5 Daniels Jon G · CIK 0001628337 · SVP, CAF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,325 Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:59 UTC |
Daniels Jon GSVP, CAF
|
SaleCommon Stock | 5,200 | $75.42 | $392,184.00 |
DisclosureSEC source: 0001170010-18-000114 · wf-form4_153022313567154.xml · nonDerivative · entry 4 Daniels Jon G · CIK 0001628337 · SVP, CAF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,809 F2 · price: The shares with respect to this transaction were sold at prices ranging from $75.33 to $75.50. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:59 UTC |
Daniels Jon GSVP, CAF
|
SaleCommon Stock | 4,800 | $76.12 | $365,376.00 |
DisclosureSEC source: 0001170010-18-000114 · wf-form4_153022313567154.xml · nonDerivative · entry 3 Daniels Jon G · CIK 0001628337 · SVP, CAF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,009 F1 · price: The shares with respect to this transaction were sold at prices ranging from $76.00 to $76.43. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:59 UTC |
Daniels Jon GSVP, CAF
|
Exercise / conversionCommon Stock | 5,200 | $42.68 | $221,936.00 |
DisclosureSEC source: 0001170010-18-000114 · wf-form4_153022313567154.xml · nonDerivative · entry 2 Daniels Jon G · CIK 0001628337 · SVP, CAF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:59 UTC |
Daniels Jon GSVP, CAF
|
Exercise / conversionCommon Stock | 4,800 | $42.68 | $204,864.00 |
DisclosureSEC source: 0001170010-18-000114 · wf-form4_153022313567154.xml · nonDerivative · entry 1 Daniels Jon G · CIK 0001628337 · SVP, CAF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:58 UTC |
Cafritz Diane LSVP & CHRO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 4,616 | $0.00 Strike: $42.68 | $0.00 |
DisclosureSEC source: 0001170010-18-000113 · wf-form4_153022310833582.xml · derivative · entry 6 Cafritz Diane L · CIK 0001702741 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,616 shares Expires 2020-04-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options became exercisable with respect to one-fourth of the underlying shares of Common Stock on each of April 15, 2014, April 15, 2015, April 15, 2016 and April 15, 2017 and are now fully exercisable. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:58 UTC |
Cafritz Diane LSVP & CHRO
|
SaleCommon Stock | 4,616 | $75.40 | $348,046.40 |
DisclosureSEC source: 0001170010-18-000113 · wf-form4_153022310833582.xml · nonDerivative · entry 2 Cafritz Diane L · CIK 0001702741 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,539 F1 · price: The shares with respect to this transaction were sold at prices ranging from $75.40 to $75.42. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:58 UTC |
Cafritz Diane LSVP & CHRO
|
Exercise / conversionCommon Stock | 4,616 | $42.68 | $197,010.88 |
DisclosureSEC source: 0001170010-18-000113 · wf-form4_153022310833582.xml · nonDerivative · entry 1 Cafritz Diane L · CIK 0001702741 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:58 UTC | GrantStock Options (Right to Buy) · Derivative | 40,086 | $0.00 Strike: $63.04 | $0.00 |
DisclosureSEC source: 0001170010-18-000094 · wf-form4_152538108710698.xml · derivative · entry 2 Wilson Charles Joseph · CIK 0001721932 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,086 Underlying: Common Stock · 40,086 shares Expires 2025-05-01 F3 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F4 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2019, May 1, 2020, May 1, 2021 and May 1, 2022. Read SEC document |
|
| May 01, 2018 Filed May 3, 2018 20:58 UTC | GrantRestricted Stock Units · Derivative | 3,054 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000094 · wf-form4_152538108710698.xml · derivative · entry 1 Wilson Charles Joseph · CIK 0001721932 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,054 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.exercise_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.expiration_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
|
| May 01, 2018 Filed May 3, 2018 20:58 UTC |
Shamim MohammadSVP and CIO
|
GrantStock Options (Right to Buy) · Derivative | 47,845 | $0.00 Strike: $63.04 | $0.00 |
DisclosureSEC source: 0001170010-18-000093 · wf-form4_152538102783269.xml · derivative · entry 2 Shamim Mohammad · CIK 0001620490 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,845 Underlying: Common Stock · 47,845 shares Expires 2025-05-01 F3 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F4 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2019, May 1, 2020, May 1, 2021 and May 1, 2022. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:58 UTC |
Shamim MohammadSVP and CIO
|
GrantRestricted Stock Units · Derivative | 3,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000093 · wf-form4_152538102783269.xml · derivative · entry 1 Shamim Mohammad · CIK 0001620490 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,645 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.exercise_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.expiration_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:57 UTC |
Reedy Thomas W JREVP & CFO
|
GrantStock Options (Right to Buy) · Derivative | 77,815 | $0.00 Strike: $63.04 | $0.00 |
DisclosureSEC source: 0001170010-18-000092 · wf-form4_152538096966511.xml · derivative · entry 2 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,815 Underlying: Common Stock · 77,815 shares Expires 2025-05-01 F3 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F4 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2019, May 1, 2020, May 1, 2021 and May 1, 2022. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:57 UTC |
Reedy Thomas W JREVP & CFO
|
GrantRestricted Stock Units · Derivative | 5,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000092 · wf-form4_152538096966511.xml · derivative · entry 1 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,928 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.exercise_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.expiration_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:56 UTC | GrantStock Options (Right to Buy) · Derivative | 40,086 | $0.00 Strike: $63.04 | $0.00 |
DisclosureSEC source: 0001170010-18-000091 · wf-form4_152538095381773.xml · derivative · entry 2 Newberry Darren C · CIK 0001721939 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,086 Underlying: Common Stock · 40,086 shares Expires 2025-05-01 F3 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F4 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2019, May 1, 2020, May 1, 2021 and May 1, 2022. Read SEC document |
|
| May 01, 2018 Filed May 3, 2018 20:56 UTC | GrantRestricted Stock Units · Derivative | 3,054 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000091 · wf-form4_152538095381773.xml · derivative · entry 1 Newberry Darren C · CIK 0001721939 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,054 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.exercise_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.expiration_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
|
| May 01, 2018 Filed May 3, 2018 20:55 UTC |
Nash William DPresident & CEO
|
GrantStock Options (Right to Buy) · Derivative | 240,513 | $0.00 Strike: $63.04 | $0.00 |
DisclosureSEC source: 0001170010-18-000090 · wf-form4_152538089544456.xml · derivative · entry 2 Nash William D · CIK 0001545342 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,513 Underlying: Common Stock · 240,513 shares Expires 2025-05-01 F3 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F4 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2019, May 1, 2020, May 1, 2021 and May 1, 2022. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:55 UTC |
Nash William DPresident & CEO
|
GrantRestricted Stock Units · Derivative | 18,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000090 · wf-form4_152538089544456.xml · derivative · entry 1 Nash William D · CIK 0001545342 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,322 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.exercise_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.expiration_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:54 UTC |
Margolin Eric MEVP, Gen. Counsel & Secretary
|
GrantStock Options (Right to Buy) · Derivative | 69,798 | $0.00 Strike: $63.04 | $0.00 |
DisclosureSEC source: 0001170010-18-000089 · wf-form4_152538087832362.xml · derivative · entry 2 MARGOLIN ERIC M · CIK 0001236893 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,798 Underlying: Common Stock · 69,798 shares Expires 2025-05-01 F3 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F4 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2019, May 1, 2020, May 1, 2021 and May 1, 2022. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:54 UTC |
Margolin Eric MEVP, Gen. Counsel & Secretary
|
GrantRestricted Stock Units · Derivative | 5,317 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000089 · wf-form4_152538087832362.xml · derivative · entry 1 MARGOLIN ERIC M · CIK 0001236893 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,317 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.exercise_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.expiration_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:54 UTC |
Lyski JamesEVP & Chief Marketing Officer
|
GrantStock Options (Right to Buy) · Derivative | 57,986 | $0.00 Strike: $63.04 | $0.00 |
DisclosureSEC source: 0001170010-18-000088 · wf-form4_152538081923113.xml · derivative · entry 2 Lyski James · CIK 0001376853 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,986 Underlying: Common Stock · 57,986 shares Expires 2025-05-01 F3 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F4 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2019, May 1, 2020, May 1, 2021 and May 1, 2022. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:54 UTC |
Lyski JamesEVP & Chief Marketing Officer
|
GrantRestricted Stock Units · Derivative | 4,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000088 · wf-form4_152538081923113.xml · derivative · entry 1 Lyski James · CIK 0001376853 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,417 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.exercise_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.expiration_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:53 UTC |
Livesay Jill AVP, Controller & PAO
|
GrantStock Options (Right to Buy) · Derivative | 25,009 | $0.00 Strike: $63.04 | $0.00 |
DisclosureSEC source: 0001170010-18-000087 · wf-form4_152538076759308.xml · derivative · entry 2 Livesay Jill A · CIK 0001456533 · VP, Controller & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,009 Underlying: Common Stock · 25,009 shares Expires 2025-05-01 F3 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F4 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2019, May 1, 2020, May 1, 2021 and May 1, 2022. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:53 UTC |
Livesay Jill AVP, Controller & PAO
|
GrantRestricted Stock Units · Derivative | 1,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000087 · wf-form4_152538076759308.xml · derivative · entry 1 Livesay Jill A · CIK 0001456533 · VP, Controller & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,905 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.exercise_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.expiration_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:52 UTC |
Hill Edwin JEVP
|
GrantStock Options (Right to Buy) · Derivative | 77,815 | $0.00 Strike: $63.04 | $0.00 |
DisclosureSEC source: 0001170010-18-000086 · wf-form4_152538075040935.xml · derivative · entry 2 Hill Edwin J · CIK 0001611830 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,815 Underlying: Common Stock · 77,815 shares Expires 2025-05-01 F3 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F4 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2019, May 1, 2020, May 1, 2021 and May 1, 2022. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:52 UTC |
Hill Edwin JEVP
|
GrantRestricted Stock Units · Derivative | 5,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000086 · wf-form4_152538075040935.xml · derivative · entry 1 Hill Edwin J · CIK 0001611830 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,928 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.exercise_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.expiration_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:52 UTC |
Daniels Jon GSVP, CAF
|
GrantStock Options (Right to Buy) · Derivative | 47,845 | $0.00 Strike: $63.04 | $0.00 |
DisclosureSEC source: 0001170010-18-000085 · wf-form4_152538073344322.xml · derivative · entry 2 Daniels Jon G · CIK 0001628337 · SVP, CAF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,845 Underlying: Common Stock · 47,845 shares Expires 2025-05-01 F3 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F4 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2019, May 1, 2020, May 1, 2021 and May 1, 2022. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:52 UTC |
Daniels Jon GSVP, CAF
|
GrantRestricted Stock Units · Derivative | 3,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000085 · wf-form4_152538073344322.xml · derivative · entry 1 Daniels Jon G · CIK 0001628337 · SVP, CAF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,645 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.exercise_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.expiration_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:52 UTC |
Cafritz Diane LSVP & CHRO
|
GrantStock Options (Right to Buy) · Derivative | 40,086 | $0.00 Strike: $63.04 | $0.00 |
DisclosureSEC source: 0001170010-18-000084 · wf-form4_152538068155595.xml · derivative · entry 2 Cafritz Diane L · CIK 0001702741 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,086 Underlying: Common Stock · 40,086 shares Expires 2025-05-01 F3 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F4 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2019, May 1, 2020, May 1, 2021 and May 1, 2022. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:52 UTC |
Cafritz Diane LSVP & CHRO
|
GrantRestricted Stock Units · Derivative | 3,054 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000084 · wf-form4_152538068155595.xml · derivative · entry 1 Cafritz Diane L · CIK 0001702741 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,054 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.exercise_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.expiration_date: The restricted stock units shall vest on May 1, 2021. F1 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 13, 2015. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:40 UTC |
Wood William C Jr.EVP & COO
|
Tax withholdingCommon Stock | 926 | $61.66 | $57,097.16 |
DisclosureSEC source: 0001170010-18-000072 · wf-form4_152477518634161.xml · nonDerivative · entry 2 Wood William C Jr. · CIK 0001483194 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,609 Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:40 UTC |
Wood William C Jr.EVP & COO
|
GrantCommon Stock | 3,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000072 · wf-form4_152477518634161.xml · nonDerivative · entry 1 Wood William C Jr. · CIK 0001483194 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,535 Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:39 UTC |
Shamim MohammadSVP and CIO
|
Tax withholdingCommon Stock | 564 | $61.66 | $34,776.24 |
DisclosureSEC source: 0001170010-18-000071 · wf-form4_152477513162134.xml · nonDerivative · entry 2 Shamim Mohammad · CIK 0001620490 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,161 Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:39 UTC |
Shamim MohammadSVP and CIO
|
GrantCommon Stock | 1,891 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000071 · wf-form4_152477513162134.xml · nonDerivative · entry 1 Shamim Mohammad · CIK 0001620490 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,725 Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:38 UTC |
Reedy Thomas W JREVP & CFO
|
Tax withholdingCommon Stock | 926 | $61.66 | $57,097.16 |
DisclosureSEC source: 0001170010-18-000070 · wf-form4_152477508260761.xml · nonDerivative · entry 2 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,089 Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:38 UTC |
Reedy Thomas W JREVP & CFO
|
GrantCommon Stock | 3,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000070 · wf-form4_152477508260761.xml · nonDerivative · entry 1 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,015 Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:37 UTC |
Nash William DPresident & CEO
|
Tax withholdingCommon Stock | 926 | $61.66 | $57,097.16 |
DisclosureSEC source: 0001170010-18-000069 · wf-form4_152477503350665.xml · nonDerivative · entry 2 Nash William D · CIK 0001545342 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,373 Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:37 UTC |
Nash William DPresident & CEO
|
GrantCommon Stock | 3,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000069 · wf-form4_152477503350665.xml · nonDerivative · entry 1 Nash William D · CIK 0001545342 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,299 Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:37 UTC |
Margolin Eric MEVP, Gen. Counsel & Secretary
|
Tax withholdingCommon Stock | 838 | $61.66 | $51,671.08 |
DisclosureSEC source: 0001170010-18-000068 · wf-form4_152477501775811.xml · nonDerivative · entry 2 MARGOLIN ERIC M · CIK 0001236893 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:37 UTC |
Margolin Eric MEVP, Gen. Counsel & Secretary
|
GrantCommon Stock | 2,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000068 · wf-form4_152477501775811.xml · nonDerivative · entry 1 MARGOLIN ERIC M · CIK 0001236893 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,338 Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:36 UTC |
Lyski JamesEVP & Chief Marketing Officer
|
Tax withholdingCommon Stock | 566 | $61.66 | $34,899.56 |
DisclosureSEC source: 0001170010-18-000067 · wf-form4_152477496895126.xml · nonDerivative · entry 2 Lyski James · CIK 0001376853 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,738 Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:36 UTC |
Lyski JamesEVP & Chief Marketing Officer
|
GrantCommon Stock | 1,891 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000067 · wf-form4_152477496895126.xml · nonDerivative · entry 1 Lyski James · CIK 0001376853 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,304 Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:36 UTC |
Hill Edwin JEVP
|
Tax withholdingCommon Stock | 689 | $61.66 | $42,483.74 |
DisclosureSEC source: 0001170010-18-000066 · wf-form4_152477491971628.xml · nonDerivative · entry 2 Hill Edwin J · CIK 0001611830 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,390 Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:36 UTC |
Hill Edwin JEVP
|
GrantCommon Stock | 2,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-18-000066 · wf-form4_152477491971628.xml · nonDerivative · entry 1 Hill Edwin J · CIK 0001611830 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,079 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.